Tolterodine tartrate NDC 27241-191

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-191Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0191Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
27241-191-05	27241019105	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-191-05)Marketed from Jun 25, 2020
27241-191-30	27241019130	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-191-30)Marketed from Jun 25, 2020
27241-191-90	27241019190	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-191-90)Marketed from Jun 25, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tolterodine tartrate
Generic name (nonproprietary): tolterodine tartrate
Active ingredients: Tolterodine tartrate — 2 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Ajanta Pharma USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213397
Marketing start: Jun 25, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 27241-191_cf018a04-660f-4119-898f-1877a5db8e7eSPL ID cf018a04-660f-4119-898f-1877a5db8e7eSPL set ID fcaca033-cd08-4b8c-9bad-7b6751faf2c9RxCUI 855182, 855189UNII 5T619TQR3RUPC 0327241192302, 0327241191305
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241019105 followed by a unit qualifier and the quantity

Package 27241-0191-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 3, 2025.

Indications (excerpt from the label)

Tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see CLINICAL STUDIES ( 14)]. Tolterodine tartrate extended-release capsules are an antimuscarinic indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213397

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213397
Product	Strength	Form · route	Labeler	Product NDC
Tolterodine tartrate	Tolterodine tartrate 4 mg/1	Capsule, Extended releaseOral	Ajanta Pharma USA Inc.	27241-192